Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GC Innovation America
AddedFeb 15, 2024
UpdatedJun 18, 2026
GC Innovation America

GC Innovation America

Public

GC Innovation America: Eco-friendly biochemical manufacturer promoting sustainable development globally.

HQ
Houston, TX, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

GC Innovation America, founded as a subsidiary of PTT Global Chemicals Plc., is dedicated to manufacturing eco-friendly biochemicals for global markets. The company’s core mission is to promote sustainable development by offering renewable feedstock-based chemicals as alternatives to petroleum-based products. Their product line includes bio-succinic acid and its derivatives, which are designed to integrate seamlessly into existing chemical-production processes. GC Innovation America focuses on providing environmentally friendly solutions to industries worldwide, aiming to reduce the ecological footprint of chemical manufacturing.

Notable affiliations include PTT Global Chemicals Plc., which supports GC Innovation America's strategic growth through international expansion and strategic partnerships. Key achievements include the successful commercialization of bio-succinic acid and derivatives, which have been adopted by various industries seeking sustainable alternatives. The overall impact of GC Innovation America lies in its contribution to reducing reliance on non-renewable resources and promoting greener industrial practices, thereby fostering a more sustainable future for the chemical industry.

GC Innovation America - Similar Companies

Genomatica logo

Genomatica

genomatica.com

GlycoSurf logo

GlycoSurf

glycosurf.com

Gevo logo

Gevo

gevo.com

Amyris logo

Amyris

amyris.com

Rennovia logo

Rennovia

NatureWorks logo

NatureWorks

natureworksllc.com

Inventure Chemicals logo

Inventure Chemicals

inventurechem.com

P2 Science logo

P2 Science

p2science.com

Rivertop Renewables logo

Rivertop Renewables

Eco Safety Products logo

Eco Safety Products

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

Modular Genetics logo

Modular Genetics

Capra Biosciences logo

Capra Biosciences

Varifas Biorenewables logo

Varifas Biorenewables

Integrity Bio-Chemicals logo

Integrity Bio-Chemicals

GC Innovation America - Quick Facts

Who are GC Innovation America's competitors?

Companies similar to GC Innovation America include Genomatica, GlycoSurf, Gevo and Amyris.

When was GC Innovation America founded?

GC Innovation America was founded in 2005.

Where is GC Innovation America's headquarters located?

GC Innovation America's headquarters is located in Houston, TX, US.

When was GC Innovation America's last funding round?

GC Innovation America's most recent funding round was for $60M (USD) in January 2011.

How much has GC Innovation America raised to-date?

As of Jan 24, 2011, GC Innovation America has raised a total of $110M (USD).

How many employees does GC Innovation America have?

GC Innovation America has 75 employees as of Feb 4, 2024.

GC Innovation America - Classification

Ownership
  • Public
Technology
  • Cleantech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biochemicals
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified